Biosimilars
🌏 NMPA Page 2NMPA news and analysis for pharmaceutical BD, investment, and market access · 5 articles on this page
Track global biosimilar approvals, market entry strategies, and regulatory pathways. Gain critical intelligence for your pharmaceutical BD and investment decisions.
Showing 13–17 of 17 articles
Biosimilar Market Growth India: Key Drivers, Challenges & Opportunities
CDSCO · autoimmune · 10 min
Dr. Yuki TanakaAdalimumab Biosimilars Uptake: Australia vs Japan Market Analysis
TGA, PMDA · autoimmune diseases · 8 min
Dr. Yuki TanakaPMDA Biosimilar Framework: Impact on Trastuzumab Biosimilars in Japan
PMDA · Oncology · 9 min
Dr. Yuki TanakaNMPA Biosimilar Approval Pathway: What You Need to Know
NMPA · biosimilars · 10 min
Dr. Yuki TanakaBevacizumab Biosimilar Approval China: NMPA Greenlights First Biosimilar
NMPA · oncology · 4 min
Dr. Yuki TanakaExplore intelligence